CooperVision Celebrates Five Years of MiSight® 1 day FDA Approval at Academy 2024 International Reception

CooperVision is once again sponsoring the Academy 2024 International Reception for eye care professionals (ECPs) from around the world. Scheduled for Friday, November 8, at 5 pm ET, this year’s gathering will celebrate the collaborative spirit of the global myopia management community and highlight the widespread global impact of the fifth anniversary of MiSight^® 1 day approval by the U.S. Food and Drug Administration.

The evening will also underscore CooperVision’s commitment to advancing optometry through education, research, and partnerships. This will include the presentation of the CooperVision-sponsored Educator of the Year awards by the International Association of Contact Lens Educators (IACLE) as well as the awarding of travel grants to ten international ECPs, enabling them to attend the Academy meeting.

“We are deeply committed to advancing collaboration with industry partners to establish myopia management as the standard of care, as well as advancing interventions that address this global epidemic. That includes our MiSight^® 1 day contact lens, the first and only FDA-approved* soft contact lens proven to help slow the progression of myopia in children, aged 8-12 at the initiation of treatment.^{† 1} This reception also extends our tradition of celebrating outstanding contact lens educators—a vital role that shapes the future of the eye care profession and patient care of tomorrow.”

Elizabeth Lumb, BSc (Hons) MCOptom, FIACLE, FBCLA, Director, Global Professional Affairs, Myopia, CooperVision

This year’s IACLE Educator of the Year Awards recipients are Dr. Aldo Ortiz (Americas Region-Guatemala), Madhumathi Subramanian (Asia Pacific Region-India), and Dr. Stefan Bandlitz (Europe/Africa/Middle East Region-Germany). Established in 2014, the program honors educators who clearly demonstrate impact on contact lens education in their institutions, including how they inspire their students to become future contact lens practitioners.

In addition, Academy Travel Grants will be formally awarded to ten ECPs, enabling them to participate in key educational experiences and professional development opportunities. They include Samson Darrah (Ghana), Tamunominabo Edah (Nigeria), Ekeoma A. Edemeraro (Nigeria), Justin Eghaghara (Nigeria), Lucy A. A. Karikari (Ghana), Chukwuemeka Jr. Obinwanne (Nigeria), Stephen Ocansey (Ghana), Grace Ogbonna (Malawi), Soumen Sadhu (India), and Asad Ullah (Pakistan).

“The 2024 CooperVision International Travel Fellowship Award provides me with an opportunity to connect with colleagues from around the world, while also staying updated on new trends in optometry,” said Dr. Tamunominabo Edah, Commander Nigerian Navy. “Most importantly, it gives me the platform to enhance my ability to mentor young optometrists by improving their leadership skills, clinical knowledge, research methodology, and the quality of their healthcare delivery.”

Guest speaker Dr. Sandra Block, President of the World Council of Optometry (WCO), will conclude the program by encouraging attendees to strengthen their commitment to making myopia management the standard of care. She will also highlight the critical role of industry partnerships in driving innovation, such as the recent launch of the WCO CooperVision Myopia Management Navigator.

For more information about Academy 2024, including details on attending the International Reception, visit https://aaopt.org/meetings/academy-2024-indianapolis.

Click HERE for the full press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

_______________________________________

* Indications for use: MiSight^® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

^†Compared to a single vision 1 day lens over a 3 year period.

References

1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight^® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567.

November 6, 2024November 7, 2024

AJsens Launches Innovative Eyewear Model Naina: A Game Changer for Makeup Lovers

AJsens announces the launch of its premier model, Naina, a fully detachable titanium frame designed specifically for beauty enthusiasts. With its ultra-lightweight design and patented technology, AJsens technology allows users to access one eye at a time while using their prescription lenses, making beauty routines easier and more enjoyable. These dual-usage frames are perfect for both daily wear and beauty applications alike.

The name “Naina,” meaning “eyes” in Hindi, reflects the essence of this sophisticated cat-eye frame. Available in three flattering colours—gold, red, and blue—Naina features warm tones that beautifully complement a variety of skin tones.

Giving Back to the Community

At its core, AJsens is dedicated to making a positive impact. A portion of the proceeds from every purchase is donated to eye health-related charities each year. Additionally, AJsens prioritizes sustainability by using eco-responsible materials. The titanium frames are complemented by vegan leather packaging and recyclable materials.

Obstacle-Free Makeup Routines with AJsens

AJsens invites all makeup lovers to explore the Naina model and enjoy a seamless, obstacle-free makeup experience. For more information, follow them on Instagram @ajsens.co or visit www.AJsens.com .

For more information, contact Anjuli Jadwani at anjuli@ajsens.com .

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

November 5, 2024November 5, 2024

Optical Vision Group Announces the Development of Telemedicine in Optometry through a Strategic Partnership with 20/20NOW and Visionix Technologies

Optical Vision Group, owner of the Entrepôt de la Lunette and Optical Warehouse banners, announces the development of telemedicine in optometry in Canada, thanks to a strategic partnership with 20/20NOW, a leader in tele-optometry, and Visionix Technologies, a globally recognized company known for its cutting-edge solutions in diagnostics, screening, and refraction.

Optical Vision Group Visionix machine — The VX 120+ from Visionix Technologies allows optometrists to perform remote eye exams (CNW Group/Optical Vision Group)

The purpose of this partnership is to implement telemedicine in optometry through Optique Avant Garde/Digital Optometrist, the optometry development banner within Optical Vision Group, opening new opportunities for eye care professionals in Quebec and other provinces.

The integration of artificial intelligence (AI) in next-generation equipment is revolutionizing the field of optometry. With these advanced technologies, optometrists can now facilitate diagnostics while accessing reliable data. Whether eye exams are performed in-person eye via tele-optometry, the quality of care is assured.

AI reduces analysis time by more than 50%, optimizing the efficiency of the examination process. This results in an increase in the number of patients treated, and, consequently, greater profitability for optometrists and businesses.

“Our commitment to innovation and making the latest technologies available has led us to this significant milestone. Launching telemedicine in optometry marks a pivotal step in making optometrists more accessible, ultimately enhancing patient care.”

Daniel Beaulieu, President, Optical Vision Group

In collaboration with Dr. Alain Desjardins, President of the Association of Affiliated Opticians and Optometrists at EDLL Inc., and Roberto Iazzolino, an optometrist with a Master’s in Optical Science from Italy, the group is advancing its development of telemedicine in optometry in Canada.

Source: Optical Vision Group

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

November 5, 2024September 16, 2024

Eye-Catching yet Wearable Frames

Voila September-October 2024 OGI Eyewear Many Thanks

We love how the fun and bold flavours of acetate colour combinations translate to metal styles in the OGI collection. Triple layers of complementary and contrasting hand-sprayed colours create eye-catching yet wearable frames. With fresh ideas and innovative techniques, OGI Eyewear promises to support the independent spirit of optical practices.

Featured model: Many Thanks

Distributed by: www.ogieyewear.com

About OGI Eyewear:

Established in 1997, we’re a design house first, an innovator with a proven record of setting industry standards, of working with top tier manufacturers and suppliers to create new eyewear designs that stay ahead of the trends.

Our releases are frequent, distinct, and tell a consistent story without overlapping existing styles across Brands. Each one of our Brands tells a unique story that identify and serve a captive audience. Think durable, handcrafted frames designed to appeal to a diverse range of lifestyles so your clients can connect with the perfect piece instead of feeling shoehorned into a more generalized look.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!

November 5, 2024November 5, 2024

Multiple CooperVision Presentations Elevate Ocular Science at Academy 2024

CooperVision has unveiled its broad scientific program for the 2024 American Academy of Optometry annual meeting, helping build clinical knowledge and practice around a range of topics such as myopia management, presbyopia, dry eye, and contact lens handling. The event is expected to draw thousands of eye care professionals (ECPs), researchers, educators, and students to Indianapolis this week.

“As a longstanding partner to the global eye care community, we strongly believe in conducting and sharing research that advances how ECPs work with patients to achieve the best possible outcomes. Our scientists and study collaborators are eager to discuss several of the timeliest topics in optometry, reinforcing CooperVision’s focus on developing innovative products whose clinical advantages are complemented by robust evidence.”

Francis Erard, Vice President of Research & Development, CooperVision

A worldwide leader in myopia management, the company will spotlight multiple works relating to the efficacy of its MiSight^® 1 day* contact lens¹ and Paragon CRT^® 100 orthokeratology contact lenses², as well as clinical practice patterns.³

Following the debut of its clariti^® 1 day multifocal with Binocular Progressive System^™ contact lenses earlier this year, CooperVision adds to the conversation at Academy with two studies that provide ECPs with information on multifocal fit success. A comparison with a differently designed daily disposable multifocal contact lens indicates better overall vision satisfaction with the unique Binocular Progressive System^™ technology⁴, while another investigation highlights patient acceptance and first fit success when moving from the original clariti^® multifocal to the new 3-Add lens.⁵

Rounding out the scientific program are a presentation from the Centre for Ocular Research & Education (CORE) that explores how symptomatic soft contact lens wearers and non-wearers can be successfully fit with Onefit^™ MED scleral lenses⁶, and another that examines the impact of lens back vertex power and material on subjective contact lens handling,⁷ which can be a discontinuation driver among patients, especially neophytes.

Additional information regarding Academy 2024, which runs from November 6-9, is available at https://aaopt.org/meetings/academy-2024-indianapolis/.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

* Indications for Use: MiSight^® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

__________________________________

References:

1 Arumugam B et al. Efficacy of MiSight^® 1 day dual focus lenses in controlling myopia progression in Chinese children. AAO 2024 poster presentation.

2 Jung L et al. Efficacy of OrthoK in axial inhibition: A comprehensive retrospective review of real-world patient population from UC Berkeley Myopia Control Clinic. AAO 2024 poster presentation.

3 Fromstein S et al. Clinical Practice Patterns for the Initial Management of Young Myopic Patients in Canada. AAO 2024 poster presentation.

4 Sulley A et al. Patient Acceptance of Two Daily Disposable Multifocal Contact Lenses. AAO 2024 poster presentation.

5 Vega J et al. Ease of Success Refitting Habitual Multifocal Soft Lens Wearers with a New Progressive Multifocal Lens System. AAO 2024 poster presentation.

6 Fadel D et al. Evaluation of Scleral Lenses in the Management of Dry Eye Symptoms. AAO 2024 poster presentation.

7 Read M et al. The impact of lens back vertex power and material on contact lens handling. AAO 2024 poster presentation.

CooperVision Celebrates Five Years of MiSight® 1 day FDA Approval at Academy 2024 International Reception

References

AJsens Launches Innovative Eyewear Model Naina: A Game Changer for Makeup Lovers

Giving Back to the Community

Obstacle-Free Makeup Routines with AJsens

Optical Vision Group Announces the Development of Telemedicine in Optometry through a Strategic Partnership with 20/20NOW and Visionix Technologies

Eye-Catching yet Wearable Frames

About OGI Eyewear:

Multiple CooperVision Presentations Elevate Ocular Science at Academy 2024

References:

Featured Posts

FYidoctors Launches National Dry Eye Treatment Program

JOS: Titan Bold

How to Cope with Depression: An EQ-Based Guide for Professionals

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

FYidoctors Launches National Dry Eye Treatment Program

JOS: Titan Bold

How to Cope with Depression: An EQ-Based Guide for Professionals

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

FYidoctors Launches National Dry Eye Treatment Program

JOS: Titan Bold

How to Cope with Depression: An EQ-Based Guide for Professionals

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

FYidoctors Launches National Dry Eye Treatment Program

JOS: Titan Bold

How to Cope with Depression: An EQ-Based Guide for Professionals

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando